New Delhi: The Central Drugs Standard Control Organisation (CDSCO), India’s apex drug controller, has approved Beyfortus, a medicine for use in all infants against Respiratory Syncytial Virus (RSV) — the top cause of hospitalisation for babies under the age of two in the country. The drug received approval in June this year, French multinational pharmaceutical … Read more
NEW YORK — Reports of a rare nervous system disorder were “more common than expected” in older U.S. adults who got the new RSV vaccines, according to a Centers for Disease Control and Prevention report released Thursday that’s similar to what the organization said earlier this year. Government officials still say the benefits of the … Read more
By Nicole Ireland The Canadian Press Posted May 17, 2024 4:26 pm 1 min read Descrease article font size Increase article font size The National Advisory Committee on Immunization is recommending a universal immunization program against respiratory syncytial virus, or RSV, for all infants. It says provinces and territories should work toward providing the antibody … Read more
NEW YORK — Health officials are investigating whether there’s a link between two new RSV vaccines and cases of a rare nervous system disorder in older U.S. adults. The inquiry is based on fewer than two dozen cases seen among more than 9.5 million vaccine recipients, health officials said Thursday. And the available information is … Read more
NEW YORK — Wastewater testing does a good job at detecting mpox infections, U.S. health officials said in a report Thursday that bolsters a push to use sewage to track more diseases. U.S. Centers for Disease Control and Prevention researchers found that over the course of a week, there was a 32% likelihood the tests … Read more
Descrease article font size Increase article font size Health Canada on Thursday approved another respiratory syncytial virus (RSV) vaccine for adults over the age of 60 and pregnant people. Pfizer’s bivalent RSV vaccine, Abrysvo, has been authorized for the use of pregnant individuals from 32 through 36 weeks gestational age for the prevention of lower respiratory … Read more
NEW YORK — Flu is picking up steam while RSV lung infections that can hit kids and older people hard may be peaking, U.S. health officials said Friday. COVID-19, though, continues to cause the most hospitalizations and deaths among respiratory illnesses — about 15,000 hospitalizations and about 1,000 deaths every week, said Dr. Mandy Cohen, … Read more
NEW YORK — RSV infections are rising sharply in some parts of the country, nearly filling hospital emergency departments in Georgia, Texas and some other states. To help counter the surge, federal officials on Thursday announced they were releasing 77,000 doses of a new RSV shot for newborns that have been in short supply. Reports … Read more
A vaccine from GlaxoSmithKline showed the potential to protect adults ages 50 to 59 from respiratory syncytial virus in a late-stage clinical trial, the company said Wednesday. The initial trial results suggest that GSK’s shot, known as Arexvy, could help protect a wider population from RSV, a disease that causes thousands of hospitalizations and deaths … Read more
WASHINGTON — Updated COVID-19 vaccines are coming soon, just in time to pair them with flu shots. And this fall, the first vaccines for another scary virus called RSV are rolling out to older adults and pregnant women. Doctors hope enough people get vaccinated to help avert another “tripledemic” like last year when hospitals were … Read more